CareRx Toekomstige groei

Future criteriumcontroles 0/6

De verwachting is dat CareRx de winst en omzet met respectievelijk 20.9% en 4.8% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 111.4% per jaar.

Belangrijke informatie

20.9%

Groei van de winst

111.4%

Groei van de winst per aandeel

Consumer Retailing winstgroei	12.2%
Inkomstengroei	4.8%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Good
Laatst bijgewerkt	30 Oct 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Winst- en omzetgroeiprognoses

OTCPK:CHHH.F - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CAD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	408	N/A	N/A	N/A	3
12/31/2025	386	-5	N/A	N/A	6
12/31/2024	354	-5	24	31	8
6/30/2024	367	-7	27	34	N/A
3/31/2024	369	-4	23	32	N/A
12/31/2023	371	-5	19	27	N/A
9/30/2023	374	-6	25	33	N/A
6/30/2023	378	-7	30	38	N/A
3/31/2023	380	-34	16	29	N/A
12/31/2022	382	-34	9	22	N/A
9/30/2022	384	-34	-4	11	N/A
6/30/2022	358	-36	-5	10	N/A
3/31/2022	311	-20	-1	8	N/A
12/31/2021	263	-23	0	7	N/A
9/30/2021	212	-21	2	7	N/A
6/30/2021	187	-24	-6	-3	N/A
3/31/2021	177	-29	-2	0	N/A
12/31/2020	162	-18	-2	0	N/A
9/30/2020	148	-50	-3	-1	N/A
6/30/2020	134	-47	-2	0	N/A
3/31/2020	126	-34	-1	2	N/A
12/31/2019	125	-46	3	6	N/A
9/30/2019	122	-19	-1	3	N/A
6/30/2019	119	-20	-2	4	N/A
3/31/2019	117	-39	5	9	N/A
12/31/2018	119	-35	2	7	N/A
9/30/2018	85	-27	8	14	N/A
6/30/2018	97	-23	5	12	N/A
3/31/2018	110	-3	N/A	15	N/A
12/31/2017	122	-4	N/A	16	N/A
9/30/2017	168	-6	N/A	14	N/A
6/30/2017	170	-3	N/A	24	N/A
3/31/2017	170	-13	N/A	10	N/A
12/31/2016	167	-18	N/A	2	N/A
9/30/2016	166	-21	N/A	6	N/A
6/30/2016	166	-34	N/A	3	N/A
3/31/2016	164	-30	N/A	20	N/A
12/31/2015	161	-35	N/A	29	N/A
9/30/2015	27	-47	N/A	28	N/A
6/30/2015	60	-48	N/A	22	N/A
3/31/2015	97	-49	N/A	18	N/A
12/31/2014	135	-44	N/A	20	N/A
9/30/2014	301	-48	N/A	23	N/A
6/30/2014	295	-43	N/A	26	N/A
3/31/2014	289	-49	N/A	24	N/A
12/31/2013	281	-39	N/A	20	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat CHHH.F de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat CHHH.F de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat CHHH.F de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van CHHH.F ( 4.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).

Hoge groei-inkomsten: De omzet van CHHH.F ( 4.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van CHHH.F naar verwachting over 3 jaar hoog zal zijn

CareRx Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

CareRx Corporation to Report Q3, 2024 Results on Nov 08, 2024

CareRx Corporation Appoints Suzanne Brand as Chief Financial Officer, Effective October 1, 2024

CareRx Corporation to Report Q2, 2024 Results on Aug 08, 2024

CareRx Corporation Announces Board Changes

CareRx Corporation Announces CFO Transition

CareRx Corporation, Annual General Meeting, May 28, 2024

CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023

CareRx Corporation to Report Q4, 2023 Results on Mar 07, 2024

CareRx Corporation to Report Q3, 2023 Results on Nov 08, 2023

CareRx Corporation to Report Q2, 2023 Results on Aug 10, 2023

Carerx Corporation Announces Director Changes

CareRx Corporation has completed a Follow-on Equity Offering in the amount of CAD 8.0001 million.

CareRx Corporation announced that it expects to receive CAD 8.0001 million in funding

CareRx Announces Retirement of Dr. Jack Shevel as Director Effective December 31, 2022

CareRx Corporation to Report Q3, 2022 Results on Nov 09, 2022

Carerx Corporation Reports Goodwill and Intangible Assets Impairment Changes for the Three Months Ended June 30, 2022

CareRx Corporation to Report Q2, 2022 Results on Aug 15, 2022

CareRx Corporation (TSX:CRRX) completed the acquisition of Hogan Pharmacy Partners Ltd.

CareRx Corporation to Report Q1, 2022 Results on May 11, 2022

CareRx Corporation Announces Executive Changes

CareRx Corporation, Annual General Meeting, Jun 07, 2022

CareRx Corporation (TSX:CRRX) entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd for $4.4 million.

CareRx Corporation (TSX:CRRX) entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd for $4.4 million.

Carerx Corporation Expands the Scope and Product Offering of Its Medical Supplies Business Under A New Brand, Revicare

CareRx Corporation (TSX:CRRX) completed the acquisition of Long-Term Care Pharmacy Division of Medical Pharmacies Group Limited for CAD 72.9 million.

CareRx Corporation (TSX:CRRX) completed the acquisition of pharmacy fulfillment centre and portion of long-term care pharmacy services business of Rexall Pharma Plus Ltd.

CareRx Corporation announced that it has received CAD 63.250644 million in funding from Yorkville Asset Management Inc.

CareRx Corporation (TSX:CRRX) acquired Fulfillment Centre in Thunder Bay, Ontario from Medical Pharmacies Group Limited.

CareRx Corporation (TSX:CRRX) entered into a definitive agreement to acquire pharmacy fulfillment centre and portion of long-term care pharmacy services business of Rexall Pharma Plus Ltd. for CAD 3.5 million.

CareRx Corporation announced that it expects to receive CAD 55.00056 million in funding from Yorkville Asset Management Inc.

CareRx Corporation to Report Q4, 2020 Results on Mar 10, 2021

CareRx Corporation and Think Research Corporation Announces Their Canada-Wide Partnership to Deliver Virtual Healthcare to Seniors

CareRx Corporation announced that it has received CAD 6.244997 million in funding from Yorkville Asset Management Inc., and other investor

CareRx Corporation announced that it expects to receive CAD 4.999998 million in funding from Yorkville Asset Management Inc., and another investor

CareRx Corporation Enters Multi-Year Pharmacy Services Agreement with an Ontario- Based Seniors Home Operator

CareRx Corporation Announces Appointment of Puneet Khanna as Senior Vice President, Corporate Development

CareRx Corporation to Report Q3, 2020 Results on Nov 05, 2020

CareRx Corporation to Report Q2, 2020 Results on Aug 06, 2020

Centric Health Corporation (TSX:CHH) completed the acquisition of Remedy Holdings Inc. from Remedy Capital Corporation, 2642943 Ontario Inc., 2745995 Ontario Inc, Jeff May and others.

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven